{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-041500","form_type":"8-K","ticker":"OGEN","cik":"0001174940","company_name":"ORAGENICS INC","filed_at":"2024-10-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:07.845228+00:00","generated_at":"2026-05-30T12:43:48.339931+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Oragenics President to present at Centurion One Capital Bahamas Summit on Oct 22, 2024","bullets":["President Michael Redmond will present and host a Q&A at the summit on October 22, 2024 at 1:20 p.m. ET.","The conference is held at Rosewood Baha Mar Hotel in Nassau, Bahamas on October 22-23, 2024.","Oragenics focuses on nasal delivery for neurology and infectious diseases, including mTBI and NPC treatments.","No financial results or material corporate developments disclosed in the press release."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-041500","json":"https://secwatch.observer/filing/0001493152-24-041500.json","markdown":"https://secwatch.observer/filing/0001493152-24-041500.md","text":"https://secwatch.observer/filing/0001493152-24-041500.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1174940/000149315224041500/0001493152-24-041500-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1174940/000149315224041500/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T12:43:48.339931+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}